Kaiju Bio is building next-generation molecular discovery and delivery platforms that enable therapeutic access to biological targets beyond the reach of conventional antibodies and small molecules.
Our technology combines ultra-large rationally designed libraries with scalable in-cell screening and modular delivery architectures to unlock new therapeutic modalities across oncology, immunology, and beyond.